👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

PepsiCo cut at Morgan Stanley as 'fundamental struggles continue'

Published 20/09/2024, 12:10
© Reuters.
PEP
-

Morgan Stanley downgraded PepsiCo (NASDAQ:PEP) from Overweight to Equal-weight in a note Friday, citing ongoing challenges with topline growth and market share losses. The firm maintained a $185 price target on the stock.

Morgan Stanley lowered its organic sales growth (OSG) and earnings-per-share (EPS) estimates, highlighting persistent softness in the U.S. market and muted category growth despite recent efforts by PepsiCo to boost spending and promotions.

Morgan Stanley had previously upgraded PepsiCo to Overweight in March, expecting a turnaround in the second half of the year as the company cycled easier comparisons, moved past Quaker recall issues, and regained pricing power.

However, the analysts admitted this call was "wrong," as weakness in the company's Frito-Lay North America (FLNA) segment continued, and beverage market share trends deteriorated.

"As FLNA OSG weakness has lingered, price interventions/higher spend do not seem to be driving a meaningful snacks topline payback, and beverage market share trends have worsened, along with moderating, albeit still solid international OSG as pricing contribution slows sequentially," wrote Morgan Stanley.

The report noted that PepsiCo's stock has risen nearly 10% from its recent lows, aligning with a broader rally in defensive large-cap stocks.

Despite the stock trading at 20x 2025 EPS, which is relatively low compared to peers, Morgan Stanley sees little upside.

"With weak group fundamentals and relatively low valuation at 20x 2025 EPS vs peers, we see PEP stock downside as limited, so are EW," the analysts wrote.

However, Morgan Stanley is concerned about further downside risk to PepsiCo's Q3, Q4, and FY25 performance, with EPS growth expected to come in below PepsiCo's high-single-digit algorithm.

The firm also warned that if recent reinvestment efforts do not generate stronger results, the need for additional spending in 2025 could further pressure earnings growth.

Morgan Stanley cut its FY25 EPS forecast by around 2%, with a 6% EPS growth estimate that is also 2% below consensus.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.